A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine

Condition:   Migraine Interventions:   Drug: Lasmiditan;   Drug: Placebo Sponsor:   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials